Generic placeholder image

Current Rheumatology Reviews

Author(s): Stephanie Mathew*, Nicole Orzechowski, Nikhil Teja, Devendra Thakur, Paige Scudder and Daniel Albert

DOI: 10.2174/1573397118666220518150230

DownloadDownload PDF Flyer Cite As
An Approach to Psychiatric Illness in Rheumatology Clinics

Page: [7 - 17] Pages: 11

  • * (Excluding Mailing and Handling)

Explore Articles
About Journal
For Authors
For Editors
For Reviewers

Abstract

Rheumatologists encounter patients with psychiatric illnesses daily in their practice; however, formal training in rheumatology does not sufficiently equip rheumatologists with guidance for managing common psychiatric illnesses. This study reviews common clinical situations involving psychiatric symptoms, their relationship with rheumatologic conditions, and their effects on clinical presentation and management. We illustrate key principles in a case-based format and reflect on the management of psychiatric components. Based on these discussions and a brief review of the epidemiology of psychiatric illnesses, we emphasize the prevalence and significance of these problems in daily practice.

Keywords: Depression, fibromyalgia, systemic lupus erythematosus, rheumatoid arthritis, giant cell arteritis, corticosteroids.

Graphical Abstract

[1]
National alliance on mental illness. 2020. Available from: https://nami.org/About-Mental-Illness/Mental-Health-by-the-Numbers/Infographics-Fact-Sheets
[2]
Sparks JA, Malspeis S, Hahn J, et al. Depression and subsequent risk for incident rheumatoid arthritis among women. Arthritis Care Res (Hoboken) 2021; 73(1): 78-89.
[http://dx.doi.org/10.1002/acr.24441] [PMID: 32937012]
[3]
Marrie RA, Hitchon CA, Walld R, et al. Increased burden of psychiatric disorders in rheumatoid arthritis. Arthritis Care Res (Hoboken) 2018; 70(7): 970-8.
[http://dx.doi.org/10.1002/acr.23539] [PMID: 29438604]
[4]
Sturgeon JA, Finan PH, Zautra AJ. Affective disturbance in rheumatoid arthritis: Psychological and disease-related pathways. Nat Rev Rheumatol 2016; 12(9): 532-42.
[http://dx.doi.org/10.1038/nrrheum.2016.112] [PMID: 27411910]
[5]
Meszaros ZS, Perl A, Faraone SV. Psychiatric symptoms in systemic lupus erythematosus: A systematic review. J Clin Psychiatry 2012; 73(7): 993-1001.
[http://dx.doi.org/10.4088/JCP.11r07425] [PMID: 22687742]
[6]
Epstein SA, Kay G, Clauw D, et al. Psychiatric disorders in patients with fibromyalgia. A multicenter investigation. Psychosomatics 1999; 40(1): 57-63.
[http://dx.doi.org/10.1016/S0033-3182(99)71272-7] [PMID: 9989122]
[7]
Conversano C, Carmassi C, Bertelloni CA, et al. Potentially traumatic events, post-traumatic stress disorder and post-traumatic stress spectrum in patients with fibromyalgia. Clin Exp Rheumatol 2019; (37 Suppl)116(1): 39-43.
[8]
van ’t Land H, Verdurmen J, Ten Have M, van Dorsselaer S, Beekman A, de Graaf R. The association between arthritis and psychiatric disorders; results from a longitudinal population-based study. J Psychosom Res 2010; 68(2): 187-93.
[http://dx.doi.org/10.1016/j.jpsychores.2009.05.011] [PMID: 20105702]
[9]
Roberts AL, Kubzansky LD, Malspeis S, Feldman CH, Costenbader KH. Association of depression with risk of incident systemic lupus erythematosus in women assessed across 2 decades. JAMA Psychiatry 2018; 75(12): 1225-33.
[http://dx.doi.org/10.1001/jamapsychiatry.2018.2462] [PMID: 30208373]
[10]
Song H, Fang F, Tomasson G, et al. Association of stress-related disorders with subsequent autoimmune disease. JAMA 2018; 319(23): 2388-400.
[http://dx.doi.org/10.1001/jama.2018.7028] [PMID: 29922828]
[11]
Prior J, Paskins Z, Whittle R, et al. Rheumatic conditions as risk factors for self-harm. Arthritis Care and Res 2021; 73(1): 130-7.
[12]
Horowitz LM, Snyder DJ, Boudreaux ED, et al. Validation of the ask suicide-screening questions for adult medical inpatients: A brief tool for all ages. Psychosomatics 2020; 61(6): 713-22.
[http://dx.doi.org/10.1016/j.psym.2020.04.008] [PMID: 32487323]
[13]
Dazzi T, Gribble R, Wessely S, Fear NT. Does asking about suicide and related behaviours induce suicidal ideation? What is the evidence? Psychol Med 2014; 44(16): 3361-3.
[http://dx.doi.org/10.1017/S0033291714001299] [PMID: 24998511]
[14]
Edwards R, Bingham C, Bathon J, et al. Catastrophising and pain in arthritis, fibromyalgia and other rheumatic diseases. Arthritis Rheum 2006; 55(2): 325-32.
[15]
Robeck I, Pohl M, Weaver M, et al. The american society of addiction medicine handbook on pain and addiction. Oxford University: Oxford Medicine Online 2018.
[16]
Yelin E, Callahan LF. The economic cost and social and psychological impact of musculoskeletal conditions. Arthritis Rheum 1995; 38(10): 1351-62.
[http://dx.doi.org/10.1002/art.1780381002] [PMID: 7575685]
[17]
Blair M, Krebs E. Fibromyalgia. Ann Intern Med 2020; 172(5): ITC33-48.
[18]
Hawro T, Krupińska-Kun M, Rabe-Jabłońska J, et al. Psychiatric disorders in patients with systemic lupus erythematosus: Association of anxiety disorder with shorter disease duration. Rheumatol Int 2011; 31(10): 1387-91.
[http://dx.doi.org/10.1007/s00296-010-1689-6] [PMID: 21136258]
[19]
Moore E, Huang MW, Putterman C. Advances in the diagnosis, pathogenesis and treatment of neuropsychiatric systemic lupus erythematosus. Curr Opin Rheumatol 2020; 32(2): 152-8.
[http://dx.doi.org/10.1097/BOR.0000000000000682] [PMID: 31895125]
[20]
Joseph FG, Lammie GA, Scolding NJ. CNS lupus: A study of 41 patients. Neurology 2007; 69(7): 544.
[http://dx.doi.org/10.1212/01.wnl.0000267320.48939.d0]
[21]
Muzyk A. Corticosteroids psychosis: Stop therapy or add psychotropics. Curr Psychiatr 2010; 9(1): 61-8.
[22]
Kudlow PA, Rosenblat JD, Weissman CR, et al. Prevalence of fibromyalgia and co-morbid bipolar disorder: A systematic review and meta-analysis. J Affect Disord 2015; 188: 134-42.
[http://dx.doi.org/10.1016/j.jad.2015.08.030] [PMID: 26363263]
[23]
McInerney SJ, Kennedy SH. Review of evidence for use of antidepressants in bipolar depression. Prim Care Companion CNS Disord 2014; 16(5)
[http://dx.doi.org/10.4088/PCC.14r01653] [PMID: 25667812]
[24]
Matcham F, Raynder L, Steer S, et al. The prevalence of depression in rheumatoid arthritis: A systematic review and meta analysis. Rheumatology 2013; 52(12): 2136-48.
[http://dx.doi.org/10.1093/rheumatology/ket169]
[25]
Bilberg A, Bremell T, Bjersing J, Mannerkorpi K. High prevalence of widespread pain in women with early rheumatoid arthritis. Scand J Rheumatol 2018; 47(6): 447-54.
[http://dx.doi.org/10.1080/03009742.2018.1447683] [PMID: 29973088]
[26]
Behm FG, Gavin IM, Karpenko O, et al. Unique immunologic patterns in fibromyalgia. BMC Clin Pathol 2012; 12(1): 25.
[http://dx.doi.org/10.1186/1472-6890-12-25] [PMID: 23245186]
[27]
Wolfe F, Clauw DJ, Fitzcharles MA, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 2010; 62(5): 600-10.
[http://dx.doi.org/10.1002/acr.20140] [PMID: 20461783]
[28]
Moret C, Briley M. Antidepressants in the treatment of fibromyalgia. Neuropsychiatr Dis Treat 2006; 2(4): 537-48.
[http://dx.doi.org/10.2147/nedt.2006.2.4.537] [PMID: 19412502]
[29]
Brill S, Ablin JN, Goor-Aryeh I, Hyat K, Slefer A, Buskila D. Prevalence of fibromyalgia syndrome in patients referred to a tertiary pain clinic. J Investig Med Off Publ Am Fed Clin Res 2012; 60(4): 685-8.
[http://dx.doi.org/10.2310/JIM.0b013e31824963d1] [PMID: 22373664]
[30]
Castro-Sánchez AM, Matarán-Peñarrocha GA, López-Rodríguez MM, Lara-Palomo IC, Arendt-Nielsen L, Fernández-de-las-Peñas C. Gender differences in pain severity, disability, depression, and widespread pressure pain sensitivity in patients with fibromyalgia syndrome without comorbid conditions. Pain Med 2012; 13(12): 1639-47.
[http://dx.doi.org/10.1111/j.1526-4637.2012.01523.x] [PMID: 23171037]
[31]
Gota CE, Kaouk S, Wilke WS. Fibromyalgia and obesity: The association between body mass index and disability, depression, history of abuse, medications, and comorbidities. J Clin Rheumatol Pract reports Rheum Musculoskelet Dis 2015; 21(6): 289-95.
[http://dx.doi.org/10.1097/RHU.0000000000000278]
[32]
Cho S-J, Sohn J-H, Bae JS, Chu MK. Fibromyalgia among patients with chronic migraine and chronic tension-type headache: A multicenter prospective cross-sectional study. Headache 2017; 57(10): 1583-92.
[http://dx.doi.org/10.1111/head.13191] [PMID: 28940352]
[33]
Küçükşen S, Genç E, Yılmaz H, et al. The prevalence of fibromyalgia and its relation with headache characteristics in episodic migraine. Clin Rheumatol 2013; 32(7): 983-90.
[http://dx.doi.org/10.1007/s10067-013-2218-2] [PMID: 23443337]
[34]
García Campayo J, Asso E, Alda M, Andres EM, Sobradiel N. Association between joint hypermobility syndrome and panic disorder: A case-control study. Psychosomatics 2010; 51(1): 55-61.
[http://dx.doi.org/10.1016/S0033-3182(10)70659-9] [PMID: 20118441]
[35]
Dreyer L, Kendall S, Danneskiold-Samsøe B, Bartels EM, Bliddal H. Mortality in a cohort of Danish patients with fibromyalgia: Increased frequency of suicide. Arthritis Rheum 2010; 62(10): 3101-8.
[http://dx.doi.org/10.1002/art.27623] [PMID: 20583101]
[36]
Wolfe F, Michaud K. Predicting depression in rheumatoid arthritis: The signal importance of pain extent and fatigue, and comorbidity. Arthritis Rheum 2009; 61(5): 667-73.
[http://dx.doi.org/10.1002/art.24428] [PMID: 19404997]
[37]
Zhao SS, Duffield S, Goodson N. The prevalence and impact of comorbid fibromyalgia in inflammatory arthritis. Best Practive Res Clin Rheumatol 2019; 33(3)
[http://dx.doi.org/10.1016/j.berh.2019.06.005]
[38]
Hanly JG, Su L, Urowitz MB, et al. Mood disorders in systemic lupus erythematosus: results from an international inception cohort study. Arthritis Rheumatol 2015; 67(7): 1837-47.
[http://dx.doi.org/10.1002/art.39111] [PMID: 25778456]
[39]
Hajduk A, Nowicka-Sauer K, Smoleńska Ż, Czuszyńska Z, Zdrojewski Z. Prevalence and correlates of suicidal thoughts in patients with neuropsychiatric lupus. Lupus 2016; 25(2): 185-92.
[http://dx.doi.org/10.1177/0961203315603136] [PMID: 26359173]
[40]
Huang X, Magder LS, Petri M. Predictors of incident depression in systemic lupus erythematosus. J Rheumatol 2014; 41(9): 1823-33.
[http://dx.doi.org/10.3899/jrheum.140111] [PMID: 25128512]
[41]
Hillhouse TM, Porter JH. A brief history of the development of antidepressant drugs: from monoamines to glutamate. Exp Clin Psychopharmacol 2015; 23(1): 1-21.
[http://dx.doi.org/10.1037/a0038550] [PMID: 25643025]
[42]
Moraczewski J, Aedma K. Tricyclic antidepressants Stat Pearls Treasure Island. (FL): StatPearls Publishing 2020.
[43]
Chu A, Wadhwa R. Selective Serotonin Reuptake Inhibitors Stat Pearls. Treasure Island (FL): StatPearls Publishing 2021.
[44]
Uçeyler N, Häuser W, Sommer C. A systematic review on the effectiveness of treatment with antidepressants in fibromyalgia syndrome. Arthritis Rheum 2008; 59(9): 1279-98.
[http://dx.doi.org/10.1002/art.24000] [PMID: 18759260]
[45]
Sansone RA, Sansone LA. Serotonin norepinephrine reuptake inhibitors: A pharmacological comparison. Innov Clin Neurosci 2014; 11(3-4): 37-42.
[PMID: 24800132]